Predictors of contraceptive discontinuation in a sexually transmitted disease clinic population

Perspectives on Sexual and Reproductive Health

Volumn 34, Issue 3, 2002, Pages 146-152

  Baron, Anna E ^b   Crane, Lori A ^b   Ramstrom, Karen C ^a   Shlay, Judith C ^c  

^a Disease Prevention Services   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; MIFEPRISTONE;

ADOLESCENT; ADULT; ARTICLE; CONTRACEPTION; CONTRACEPTIVE DEVICE; CORRELATION ANALYSIS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREDICTION; PREGNANCY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT;

ADOLESCENT; ADULT; COHORT STUDIES; COLORADO; COMMUNITY HEALTH CENTERS; CONTRACEPTION; CONTRACEPTION BEHAVIOR; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RISK-TAKING; SEXUALLY TRANSMITTED DISEASES;

EID: 0036590160     PISSN: 15386341     EISSN: None     Source Type: Journal    
DOI: 10.2307/3097713     Document Type: Article

References (57)

1. Price SJ et al., Use of contraception in women who present for termination of pregnancy in inner London, Public Health, 1997, 111(6):377-382; Savonius H, Pakarinen P and Kajanoja P, Reasons for pregnancy termination: negligence or failure of contraception? Acta Obstetricia et Gynecolgica Scandinavica, 1995, 74(10):818-821; and Clark JB, Holt VL and Miser F, Unintended pregnancy among female soldiers presenting for prenatal care at Madigan Army Medical Center, Military Medicine, 1998, 163(7):444-448.
2. Price SJ et al., Use of contraception in women who present for termination of pregnancy in inner London, Public Health, 1997, 111(6):377-382; Savonius H, Pakarinen P and Kajanoja P, Reasons for pregnancy termination: negligence or failure of contraception? Acta Obstetricia et Gynecolgica Scandinavica, 1995, 74(10):818-821; and Clark JB, Holt VL and Miser F, Unintended pregnancy among female soldiers presenting for prenatal care at Madigan Army Medical Center, Military Medicine, 1998, 163(7):444-448.
3. Price SJ et al., Use of contraception in women who present for termination of pregnancy in inner London, Public Health, 1997, 111(6):377-382; Savonius H, Pakarinen P and Kajanoja P, Reasons for pregnancy termination: negligence or failure of contraception? Acta Obstetricia et Gynecolgica Scandinavica, 1995, 74(10):818-821; and Clark JB, Holt VL and Miser F, Unintended pregnancy among female soldiers presenting for prenatal care at Madigan Army Medical Center, Military Medicine, 1998, 163(7):444-448.
4. Rosenberg MJ, Waugh MS and Long L, Unintended pregnancies and use, misuse and discontinuation of oral contraceptives, Journal of Reproductive Medicine, 1995, 40(5):355-360.
5. Trussell J and Vaughn B, Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth, Family Planning Perspectives, 1999, 31(2):64-72 & 93; and Hammerslough CR, Characteristics of women who stop using contraceptives, Family Planning Perspectives, 1984, 15(1):14-18.
6. Trussell J and Vaughn B, Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth, Family Planning Perspectives, 1999, 31(2):64-72 & 93; and Hammerslough CR, Characteristics of women who stop using contraceptives, Family Planning Perspectives, 1984, 15(1):14-18.
7. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
8. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
9. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
10. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
11. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
12. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
13. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
14. Rosenberg MJ and Waugh MS, Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons, American Journal of Obstetrics and Gynecology, 1998, 179(3):577-582; Sangi-Haghpeykar H et al., Experiences of injectable contraceptive users in an urban setting, Obstetrics & Gynecology, 1996, 88(2):227-233; Polaneczky M et al., Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population, Family Planning Perspectives, 1996, 28(4):174-178; Sivin I et al., Levonorgestrel capsule implants in the United States: a 5-year study, Obstetrics & Gynecology, 1998, 92(3):337-344; Kalmuss D et al., Determinants of early implant discontinuation among low-income women, Family Planning Perspectives, 1996, 28(6):256-260; Suman VJ et al., Levonorgestrel contraceptive implants in female patients 14 to 21 years old, Mayo Clinic Proceedings, 1998, 73(1):10-16; O'Dell CM et al., Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents, Obstetrics & Gynecology, 1998, 91(4):609-614; and Stevens-Simons C and Kelly L, Correlates and consequences of early removal of levonorgestrel implants among teenaged mothers, Archives of Pediatric and Adolescent Medicine, 1998, 152(9):893-898.
15. Price SJ et al., 1997, op. cit. (see reference 1); Savonius H, Pakarinen P and Kajanoja P, 1995, op. cit. (see reference 1); and Clark JB, Holt VL and Miser F, 1998, op. cit. (see reference 1).
16. Price SJ et al., 1997, op. cit. (see reference 1); Savonius H, Pakarinen P and Kajanoja P, 1995, op. cit. (see reference 1); and Clark JB, Holt VL and Miser F, 1998, op. cit. (see reference 1).
17. Price SJ et al., 1997, op. cit. (see reference 1); Savonius H, Pakarinen P and Kajanoja P, 1995, op. cit. (see reference 1); and Clark JB, Holt VL and Miser F, 1998, op. cit. (see reference 1).
18. Larsson G et al., A longitudinal study of birth control and pregnancy outcome among women in a Swedish population, Contraception, 1997, 56(1):9-16.
19. Savonius H, Pakarinen P and Kajanoja P, 1995, op. cit. (see reference 1); and Clark JB, Holt VL and Miser F, 1998, op. cit. (see reference 1).
20. Savonius H, Pakarinen P and Kajanoja P, 1995, op. cit. (see reference 1); and Clark JB, Holt VL and Miser F, 1998, op. cit. (see reference 1).
21. Rosenberg MJ, Waugh MS and Burnhill MS, Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation, Family Planning Perspectives, 1998, 30(2):89-92 & 104.
22. Trussell J and Vaughn B, 1999, op. cit. (see reference 3).
23. Cramer JA, Compliance with contraceptives and other treatments, Obstetrics & Gynecology, 1996, 88(Suppl.):4S-12S.
24. Beckman LJ and Harvey SM, Factors affecting the consistent use of barrier methods of contraception, Obstetrics & Gynecology, 1996, 88(Suppl.):65S-71S.
25. Upchurch DM et al., Contraceptive needs and practices among women attending an inner-city STD clinic, American Journal of Public Health, 1987, 77(11):1427-1430.
26. Glei DA, Measuring contraceptive use patterns among teenage and adult women, Family Planning Perspectives, 1999, 31(2):73-80; Trussell J and Vaughn B, 1999, op. cit. (see reference 3); Hammerslough CR, 1984, op. cit. (see reference 3); Grady WR, Hayward MD and Florey FA, Contraceptive discontinuation among married women in the United States, Studies in Family Planning, 1988, 19(4):227-235; Kalmuss D et al., 1996, op. cit. (see reference 4); O'Dell CM et al., 1998, op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
27. Glei DA, Measuring contraceptive use patterns among teenage and adult women, Family Planning Perspectives, 1999, 31(2):73-80; Trussell J and Vaughn B, 1999, op. cit. (see reference 3); Hammerslough CR, 1984, op. cit. (see reference 3); Grady WR, Hayward MD and Florey FA, Contraceptive discontinuation among married women in the United States, Studies in Family Planning, 1988, 19(4):227-235; Kalmuss D et al., 1996, op. cit. (see reference 4); O'Dell CM et al., 1998, op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
28. Glei DA, Measuring contraceptive use patterns among teenage and adult women, Family Planning Perspectives, 1999, 31(2):73-80; Trussell J and Vaughn B, 1999, op. cit. (see reference 3); Hammerslough CR, 1984, op. cit. (see reference 3); Grady WR, Hayward MD and Florey FA, Contraceptive discontinuation among married women in the United States, Studies in Family Planning, 1988, 19(4):227-235; Kalmuss D et al., 1996, op. cit. (see reference 4); O'Dell CM et al., 1998, op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
29. Glei DA, Measuring contraceptive use patterns among teenage and adult women, Family Planning Perspectives, 1999, 31(2):73-80; Trussell J and Vaughn B, 1999, op. cit. (see reference 3); Hammerslough CR, 1984, op. cit. (see reference 3); Grady WR, Hayward MD and Florey FA, Contraceptive discontinuation among married women in the United States, Studies in Family Planning, 1988, 19(4):227-235; Kalmuss D et al., 1996, op. cit. (see reference 4); O'Dell CM et al., 1998, op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
30. Glei DA, Measuring contraceptive use patterns among teenage and adult women, Family Planning Perspectives, 1999, 31(2):73-80; Trussell J and Vaughn B, 1999, op. cit. (see reference 3); Hammerslough CR, 1984, op. cit. (see reference 3); Grady WR, Hayward MD and Florey FA, Contraceptive discontinuation among married women in the United States, Studies in Family Planning, 1988, 19(4):227-235; Kalmuss D et al., 1996, op. cit. (see reference 4); O'Dell CM et al., 1998, op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
31. Glei DA, Measuring contraceptive use patterns among teenage and adult women, Family Planning Perspectives, 1999, 31(2):73-80; Trussell J and Vaughn B, 1999, op. cit. (see reference 3); Hammerslough CR, 1984, op. cit. (see reference 3); Grady WR, Hayward MD and Florey FA, Contraceptive discontinuation among married women in the United States, Studies in Family Planning, 1988, 19(4):227-235; Kalmuss D et al., 1996, op. cit. (see reference 4); O'Dell CM et al., 1998, op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
32. Glei DA, Measuring contraceptive use patterns among teenage and adult women, Family Planning Perspectives, 1999, 31(2):73-80; Trussell J and Vaughn B, 1999, op. cit. (see reference 3); Hammerslough CR, 1984, op. cit. (see reference 3); Grady WR, Hayward MD and Florey FA, Contraceptive discontinuation among married women in the United States, Studies in Family Planning, 1988, 19(4):227-235; Kalmuss D et al., 1996, op. cit. (see reference 4); O'Dell CM et al., 1998, op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
33. Rosenberg MJ and Waugh MS, 1998, op. cit. (see reference 4); and Sangi-Haghpeykar H et al., 1996, op. cit. (see reference 4).
34. Rosenberg MJ and Waugh MS, 1998, op. cit. (see reference 4); and Sangi-Haghpeykar H et al., 1996, op. cit. (see reference 4).
35. Trussell J and Vaughn B, 1999, op. cit. (see reference 3).
36. I b i d.
37. I b i d.
38. Trussell J and Kowal D, The essentials of contraception: efficacy, safety, and personal considerations, in: Hatcher RA et al., eds., Contraceptive Technology, 17th rev. ed., New York: Ardent Media, 1998; and Piccinino LJ and Mosher WD, Trends in contraceptive use in the United States: 1982-1995, Family Planning Perspectives, 1998, 30(1):4-10 & 46.
39. Trussell J and Kowal D, The essentials of contraception: efficacy, safety, and personal considerations, in: Hatcher RA et al., eds., Contraceptive Technology, 17th rev. ed., New York: Ardent Media, 1998; and Piccinino LJ and Mosher WD, Trends in contraceptive use in the United States: 1982-1995, Family Planning Perspectives, 1998, 30(1):4-10 & 46.
40. O'Dell CM et al., 1998, op. cit. (see reference 4).
41. Haynes RB et al., Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions, Clinical Pharmacology and Therapeutics, 1977, 22(2):125-129.
42. Price SJ et al., 1997, op. cit. (see reference 1); Polaneczky M et al., 1996, op. cit. (see reference 4); Sivin I et al., 1998, op. cit. (see reference 4); Larsson G et al., 1997, op. cit. (see reference 6); Davidson AR et al., Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women, American Journal of Public Health, 1997, 87(9):1532-1534; and Paul C, Skegg DCG and Williams S, Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation, Contraception, 1997, 56(4):209-214.
43. Price SJ et al., 1997, op. cit. (see reference 1); Polaneczky M et al., 1996, op. cit. (see reference 4); Sivin I et al., 1998, op. cit. (see reference 4); Larsson G et al., 1997, op. cit. (see reference 6); Davidson AR et al., Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women, American Journal of Public Health, 1997, 87(9):1532-1534; and Paul C, Skegg DCG and Williams S, Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation, Contraception, 1997, 56(4):209-214.
44. Price SJ et al., 1997, op. cit. (see reference 1); Polaneczky M et al., 1996, op. cit. (see reference 4); Sivin I et al., 1998, op. cit. (see reference 4); Larsson G et al., 1997, op. cit. (see reference 6); Davidson AR et al., Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women, American Journal of Public Health, 1997, 87(9):1532-1534; and Paul C, Skegg DCG and Williams S, Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation, Contraception, 1997, 56(4):209-214.
45. Price SJ et al., 1997, op. cit. (see reference 1); Polaneczky M et al., 1996, op. cit. (see reference 4); Sivin I et al., 1998, op. cit. (see reference 4); Larsson G et al., 1997, op. cit. (see reference 6); Davidson AR et al., Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women, American Journal of Public Health, 1997, 87(9):1532-1534; and Paul C, Skegg DCG and Williams S, Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation, Contraception, 1997, 56(4):209-214.
46. Price SJ et al., 1997, op. cit. (see reference 1); Polaneczky M et al., 1996, op. cit. (see reference 4); Sivin I et al., 1998, op. cit. (see reference 4); Larsson G et al., 1997, op. cit. (see reference 6); Davidson AR et al., Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women, American Journal of Public Health, 1997, 87(9):1532-1534; and Paul C, Skegg DCG and Williams S, Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation, Contraception, 1997, 56(4):209-214.
47. Price SJ et al., 1997, op. cit. (see reference 1); Polaneczky M et al., 1996, op. cit. (see reference 4); Sivin I et al., 1998, op. cit. (see reference 4); Larsson G et al., 1997, op. cit. (see reference 6); Davidson AR et al., Injectable contraceptive discontinuation and subsequent unintended pregnancy among low-income women, American Journal of Public Health, 1997, 87(9):1532-1534; and Paul C, Skegg DCG and Williams S, Depot medroxyprogesterone acetate: patterns of use and reasons for discontinuation, Contraception, 1997, 56(4):209-214.
48. Kalmuss D et al., 1996, op. cit. (see reference 4).
49. Ibid.; Rosenberg MJ and Waugh MS, 1998, op. cit. (see reference 4); O'Dell CM et al., 1998 op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
50. Ibid.; Rosenberg MJ and Waugh MS, 1998, op. cit. (see reference 4); O'Dell CM et al., 1998 op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
51. Ibid.; Rosenberg MJ and Waugh MS, 1998, op. cit. (see reference 4); O'Dell CM et al., 1998 op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
52. Ibid.; Rosenberg MJ and Waugh MS, 1998, op. cit. (see reference 4); O'Dell CM et al., 1998 op. cit. (see reference 4); and Stevens-Simons C and Kelly L, 1998, op. cit. (see reference 4).
53. Branden PS, Contraceptive choice and patient compliance: the health care provider's challenge, Journal of Nurse Midwifery, 1998, 43(6): 471-482.
54. Rosenberg MJ and Waugh MS, 1998, op cit. (see reference 4).
55. Trussell J and Vaughn B, 1999, op. cit. (see reference 3).
56. Hammerslough CR, 1984, op. cit. (see reference 3).
57. Sable M and Libbus MK, Beliefs concerning contraceptive acquisition and use among low-income women, Journal of Health Care for the Poor and Underserved, 1998, 9(3):262-275.